​

Nanobiotix (NBTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

NBTX Stock Forecast

Nanobiotix (NBTX) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $38.00, with a high of $46.00 and a low of $30.00. This represents a -5.89% decline from the last price of $40.38.

- $10 $20 $30 $40 $50 High: $46 Avg: $38 Low: $30 Last Closed Price: $40.38

NBTX Stock Rating

Nanobiotix stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

NBTX Price Target Upside V Benchmarks

TypeNameUpside
StockNanobiotix-5.89%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-24
Avg Price Target-$38.00$29.00
Last Closing Price$40.38$40.38$40.38
Upside/Downside--5.89%-28.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-52--7
Jun, 26-52--7
May, 2615---6
Apr, 26-6---6
Mar, 26-6---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 04, 2026Jonathan ChangLeerink Partners$46.00$35.2030.68%13.92%
May 01, 2026UBS$30.00$34.62-13.34%-25.71%
Nov 25, 2025Jonathan ChangLeerink Partners$26.00$22.0018.18%-35.61%
Sep 18, 2025Jonathan ChangLeerink Partners$14.00$12.3113.73%-65.33%
Aug 27, 2024Michael SchmidtGuggenheim$12.00$5.13133.92%-70.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 18, 2026H.C. WainwrightBuyBuyhold
May 01, 2026UBSNeutralNeutralhold
Mar 12, 2026Cowen & Co.BuyBuyhold
Feb 06, 2026Cowen & Co.Buyinitialise
Nov 25, 2025Leerink PartnersOutperformOutperformhold
Nov 04, 2025H.C. WainwrightBuyBuyhold
Sep 19, 2025H.C. WainwrightBuyBuyhold
Aug 27, 2024GuggenheimBuyinitialise

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.35$-1.64$-1.08-----
Avg Forecast$-1.96$-1.46$-1.31$-1.06$-0.90$-0.83$1.44$0.70
High Forecast$-0.75$-0.37$-0.86$-1.02$-0.39$-0.23$2.57$1.25
Low Forecast$-3.18$-2.51$-1.75$-1.09$-1.40$-1.48$0.40$0.20
Surprise %-31.12%12.33%-17.56%-----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.00K$4.78M$30.06M-----
Avg Forecast$7.72M$2.68M$19.34M$20.96M$29.82M$37.73M$150.46M$118.41M
High Forecast$11.38M$4.18M$35.47M$26.66M$46.73M$60.50M$241.24M$189.85M
Low Forecast$4.05M$1.14M$3.20M$15.25M$12.91M$16.86M$67.22M$52.90M
Surprise %-99.87%78.16%55.45%-----

Net Income Forecast

$-150M $-100M $-50M $0 $50M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-47.00M$-57.04M$-39.70M-----
Avg Forecast$-72.49M$-53.75M$-48.44M$-39.10M$-33.09M$-30.63M$53.13M$25.92M
High Forecast$-27.71M$-13.58M$-31.74M$-37.77M$-14.24M$-8.60M$94.80M$46.24M
Low Forecast$-117.25M$-92.70M$-64.73M$-40.42M$-51.56M$-54.65M$14.92M$7.28M
Surprise %-35.16%6.12%-18.05%-----

NBTX Forecast FAQ

Is Nanobiotix stock a buy?

Nanobiotix stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Nanobiotix is a favorable investment for most analysts.

What is Nanobiotix's price target?

Nanobiotix's price target, set by 4 Wall Street analysts, averages $38 over the next 12 months. The price target range spans from $30 at the low end to $46 at the high end, suggesting a potential -5.89% change from the previous closing price of $40.38.

How does Nanobiotix stock forecast compare to its benchmarks?

Nanobiotix's stock forecast shows a -5.89% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Nanobiotix over the past three months?

  • July 2026: 0% Strong Buy, 71.43% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 71.43% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Nanobiotix’s EPS forecast?

Nanobiotix's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.06, marking a -1.85% decrease from the reported $-1.08 in 2023. Estimates for the following years are $-0.9 in 2025, $-0.83 in 2026, $1.44 in 2027, and $0.7 in 2028.

What is Nanobiotix’s revenue forecast?

Nanobiotix's average annual revenue forecast for its fiscal year ending in December 2024 is $20.96M, reflecting a -30.26% decrease from the reported $30.06M in 2023. The forecast for 2025 is $29.82M, followed by $37.73M for 2026, $150.46M for 2027, and $118.41M for 2028.

What is Nanobiotix’s net income forecast?

Nanobiotix's net income forecast for the fiscal year ending in December 2024 stands at $-39.098M, representing a -1.52% decrease from the reported $-39.7M in 2023. Projections indicate $-33.092M in 2025, $-30.627M in 2026, $53.13M in 2027, and $25.92M in 2028.